Bank Of Montreal

Direxion Daily Small Cap Bull 3X ETF

SPDR S&P Retail ETF

ProShares UltraPro Dow30

ProShares UltraShort Bloomberg Natrl Gas

Guggenheim Solar ETF

Direxion Technology Bear 3X Shares

Materials Select Sector SPDR

ProShares Trust ProShares Short Bitcoin Strategy ETF

ProShares Bitcoin Strategy ETF

Direxion Daily Small Cap Bear 3X ETF

ProShares Ultra Bloomberg Natural Gas

Direxion Daily Technology Bull 3X ETF

ARK Innovation ETF

Direxion Dly S&P Oil&Gs Ex&Prd Br 3X ETF

Magal Security Systems Ltd.

Direxion Financial Bear 3X Shar

Direxion Daily Semicondct Bull 3X ETF

JELD-WEN Holding Inc. Common Stock

Las Vegas Sands Corp. Common Stock

Century Communities Inc. Common Stock

Kontoor Brands Inc. Common Stock

Bath & Body Works Inc.

RLJ Lodging Trust Common Shares of Beneficial Interest $0.01 par value

Leggett & Platt Incorporated Common Stock

Snap Inc. Class A Common Stock

Cleveland-Cliffs Inc. Common Stock

Civitas Resources Inc. Common Stock

Archer Aviation Inc. Class A Common Stock

AMC Entertainment Holdings Inc. Class A Common Stock

Oklo Inc.

QuantumScape Corporation Class A Common Stock

Sea Limited American Depositary Shares each representing one Class A Ordinary Share

Cameco Corporation Common Stock

Twilio Inc. Class A Common Stock

Spotify Technology S.A. Ordinary Shares

Cloudflare Inc. Class A Common Stock

Molina Healthcare Inc Common Stock

Click here to get full coverage on What drives BHVN stock price - Remarkable growth - Jammu Links News

What drives BHVN stock price - Remarkable growth  Jammu Links News

What drives BHVN stock price - Remarkable growth - Jammu Links News

Click here to get full coverage on Law Offices of Frank R. Cruz Encourages Biohaven Ltd. (BHVN) Investors To Inquire About Securities Fraud Class Action - Business Wire

Law Offices of Frank R. Cruz Encourages Biohaven Ltd. (BHVN) Investors To Inquire About Securities Fraud Class Action  Business Wire

Law Offices of Frank R. Cruz Encourages Biohaven Ltd. (BHVN) Investors To Inquire About Securities Fraud Class Action - Business Wire

Click here to get full coverage on Biohaven Ltd. (BHVN) Collaborates with Bexorg, Inc to Target Central Nervous System Disorders - yahoo.co

Biohaven Ltd. (BHVN) Collaborates with Bexorg, Inc to Target Central Nervous System Disorders  yahoo.co

Biohaven Ltd. (BHVN) Collaborates with Bexorg, Inc to Target Central Nervous System Disorders - yahoo.co

Click here to get full coverage on BHVN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Biohaven Ltd. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - PR Newswire

BHVN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Biohaven Ltd. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit  PR Newswire

BHVN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Biohaven Ltd. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - PR Newswire

Click here to get full coverage on BHVN Investor Notice: Robbins LLP Reminds Biohaven Ltd. Stockholders of the Securities Fraud Class Action Lawsuit - GlobeNewswire

BHVN Investor Notice: Robbins LLP Reminds Biohaven Ltd. Stockholders of the Securities Fraud Class Action Lawsuit  GlobeNewswire

BHVN Investor Notice: Robbins LLP Reminds Biohaven Ltd. Stockholders of the Securities Fraud Class Action Lawsuit - GlobeNewswire

Click here to get full coverage on Kirby McInerney LLP Reminds Biohaven Ltd. (BHVN) Investors of Class Action Filing and Encourages Investors to Contact the Firm - TradingView

Kirby McInerney LLP Reminds Biohaven Ltd. (BHVN) Investors of Class Action Filing and Encourages Investors to Contact the Firm  TradingView

Kirby McInerney LLP Reminds Biohaven Ltd. (BHVN) Investors of Class Action Filing and Encourages Investors to Contact the Firm - TradingView

Click here to get full coverage on BHVN Investors Have Opportunity to Lead Biohaven Ltd. Securities Fraud Lawsuit with the Schall Law Firm - Eastern Progress

BHVN Investors Have Opportunity to Lead Biohaven Ltd. Securities Fraud Lawsuit with the Schall Law Firm  Eastern Progress

BHVN Investors Have Opportunity to Lead Biohaven Ltd. Securities Fraud Lawsuit with the Schall Law Firm - Eastern Progress

Click here to get full coverage on Biohaven: Cash Hog Awaits FDA Decision On SCA - Seeking Alpha

Biohaven: Cash Hog Awaits FDA Decision On SCA  Seeking Alpha

Biohaven: Cash Hog Awaits FDA Decision On SCA - Seeking Alpha

Click here to get full coverage on What analysts say about BHVN stock - Breakthrough capital growth - Jammu Links News

What analysts say about BHVN stock - Breakthrough capital growth  Jammu Links News

What analysts say about BHVN stock - Breakthrough capital growth - Jammu Links News

Click here to get full coverage on Law Offices of Howard G. Smith Encourages Biohaven Ltd. (BHVN) Investors To Inquire About Securities Fraud Class Action - Business Wire

Law Offices of Howard G. Smith Encourages Biohaven Ltd. (BHVN) Investors To Inquire About Securities Fraud Class Action  Business Wire

Law Offices of Howard G. Smith Encourages Biohaven Ltd. (BHVN) Investors To Inquire About Securities Fraud Class Action - Business Wire

Click here to get full coverage on Rosen Law Firm Urges Biohaven Ltd. (NYSE: BHVN) Stockholders to Contact the Firm for Information About Their Rights - PR Newswire

Rosen Law Firm Urges Biohaven Ltd. (NYSE: BHVN) Stockholders to Contact the Firm for Information About Their Rights  PR Newswire

Rosen Law Firm Urges Biohaven Ltd. (NYSE: BHVN) Stockholders to Contact the Firm for Information About Their Rights - PR Newswire

Click here to get full coverage on Biohaven ($BHVN) Regulatory Misstatements, Clinical Setbacks, and Drug Approval Risks Case - TradingView

Biohaven ($BHVN) Regulatory Misstatements, Clinical Setbacks, and Drug Approval Risks Case  TradingView

Biohaven ($BHVN) Regulatory Misstatements, Clinical Setbacks, and Drug Approval Risks Case - TradingView

Click here to get full coverage on BHVN Stock Analysis and Forecast - Free Stock Movement Tracking - Jammu Links News

BHVN Stock Analysis and Forecast - Free Stock Movement Tracking  Jammu Links News

BHVN Stock Analysis and Forecast - Free Stock Movement Tracking - Jammu Links News

Click here to get full coverage on Biohaven Ltd. (BHVN) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation - Business Wire

Biohaven Ltd. (BHVN) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation  Business Wire

Biohaven Ltd. (BHVN) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation - Business Wire

Click here to get full coverage on Securities Fraud Investigation Into Biohaven Ltd. (BHVN) Announced – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz - Business Wire

Securities Fraud Investigation Into Biohaven Ltd. (BHVN) Announced – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz  Business Wire

Securities Fraud Investigation Into Biohaven Ltd. (BHVN) Announced – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz - Business Wire

Click here to get full coverage on Biohaven Highlights Innovation and Advancement Across MoDE and TRAP Degrader Platform at R&D Day, Announcing Positive TRAP Degrader Data Achieving > 80% Sustained Reductions in Galactose-Deficient IgA1 (Gd-IgA1) with Potential First-in-Class - PR Newswire

Biohaven Highlights Innovation and Advancement Across MoDE and TRAP Degrader Platform at R&D Day, Announcing Positive TRAP Degrader Data Achieving > 80% Sustained Reductions in Galactose-Deficient IgA1 (Gd-IgA1) with Potential First-in-Class  PR Newswire

Biohaven Highlights Innovation and Advancement Across MoDE and TRAP Degrader Platform at R&D Day, Announcing Positive TRAP Degrader Data Achieving > 80% Sustained Reductions in Galactose-Deficient IgA1 (Gd-IgA1) with Potential First-in-Class - PR Newswire

Click here to get full coverage on Rosen Law Firm Urges Biohaven Ltd. (NYSE: BHVN) Stockholders to Contact the Firm for Information About Their Rights - Business Wire

Rosen Law Firm Urges Biohaven Ltd. (NYSE: BHVN) Stockholders to Contact the Firm for Information About Their Rights  Business Wire

Rosen Law Firm Urges Biohaven Ltd. (NYSE: BHVN) Stockholders to Contact the Firm for Information About Their Rights - Business Wire

Click here to get full coverage on Biohaven Reports Recent Business Developments and Fourth Quarter and Full Year 2024 Financial Results - PR Newswire

Biohaven Reports Recent Business Developments and Fourth Quarter and Full Year 2024 Financial Results  PR Newswire

Biohaven Reports Recent Business Developments and Fourth Quarter and Full Year 2024 Financial Results - PR Newswire

Click here to get full coverage on Is BHVN a good long term investment - Strong return on assets - Jammu Links News

Is BHVN a good long term investment - Strong return on assets  Jammu Links News

Is BHVN a good long term investment - Strong return on assets - Jammu Links News

Click here to get full coverage on Biohaven Ltd. (BHVN) Collaborates with Bexorg, Inc to Target Central Nervous System Disorders - MSN

Biohaven Ltd. (BHVN) Collaborates with Bexorg, Inc to Target Central Nervous System Disorders  MSN

Biohaven Ltd. (BHVN) Collaborates with Bexorg, Inc to Target Central Nervous System Disorders - MSN

Click here to get full coverage on Biohaven Announces Investment up to $600 Million by Oberland Capital - PR Newswire

Biohaven Announces Investment up to $600 Million by Oberland Capital  PR Newswire

Biohaven Announces Investment up to $600 Million by Oberland Capital - PR Newswire

Click here to get full coverage on Biohaven Ltd. (BHVN) Lawsuit - Investors Urged to Contact Levi & Korsinsky Before September 12, 2025 - ACCESS Newswire

Biohaven Ltd. (BHVN) Lawsuit - Investors Urged to Contact Levi & Korsinsky Before September 12, 2025  ACCESS Newswire

Biohaven Ltd. (BHVN) Lawsuit - Investors Urged to Contact Levi & Korsinsky Before September 12, 2025 - ACCESS Newswire

Click here to get full coverage on Interesting BHVN Put And Call Options For November 21st - Nasdaq

Interesting BHVN Put And Call Options For November 21st  Nasdaq

Interesting BHVN Put And Call Options For November 21st - Nasdaq

Click here to get full coverage on Biohaven Reports Positive Degrader Data Achieving > 80% Sustained Reductions in Total IgG with Potential First-in-Class BHV-1300 - PR Newswire

Biohaven Reports Positive Degrader Data Achieving > 80% Sustained Reductions in Total IgG with Potential First-in-Class BHV-1300  PR Newswire

Biohaven Reports Positive Degrader Data Achieving > 80% Sustained Reductions in Total IgG with Potential First-in-Class BHV-1300 - PR Newswire

Click here to get full coverage on Biohaven Announces FDA Acceptance and Priority Review of Troriluzole New Drug Application for the Treatment of Spinocerebellar Ataxia - PR Newswire

Biohaven Announces FDA Acceptance and Priority Review of Troriluzole New Drug Application for the Treatment of Spinocerebellar Ataxia  PR Newswire

Biohaven Announces FDA Acceptance and Priority Review of Troriluzole New Drug Application for the Treatment of Spinocerebellar Ataxia - PR Newswire

Click here to get full coverage on Is BHVN a good long term investment - Phenomenal wealth increase - Jammu Links News

Is BHVN a good long term investment - Phenomenal wealth increase  Jammu Links News

Is BHVN a good long term investment - Phenomenal wealth increase - Jammu Links News

Click here to get full coverage on Biohaven Reports Third Quarter 2024 Financial Results and Recent Business Developments - PR Newswire

Biohaven Reports Third Quarter 2024 Financial Results and Recent Business Developments  PR Newswire

Biohaven Reports Third Quarter 2024 Financial Results and Recent Business Developments - PR Newswire

Click here to get full coverage on Biohaven Ltd. (BHVN)’s BHV-1400 Cuts Disease Antibody by 81% in IgA Nephropathy - Yahoo Finance

Biohaven Ltd. (BHVN)’s BHV-1400 Cuts Disease Antibody by 81% in IgA Nephropathy  Yahoo Finance

Biohaven Ltd. (BHVN)’s BHV-1400 Cuts Disease Antibody by 81% in IgA Nephropathy - Yahoo Finance

Click here to get full coverage on Biohaven Reports Positive Phase 1 Degrader Data, Achieving Deep Targeted IgG Reductions in the Lowest Subcutaneous Dose Tested; Announces NDA Submission for Troriluzole in SCA and Provides Other Key Program Updates - PR Newswire

Biohaven Reports Positive Phase 1 Degrader Data, Achieving Deep Targeted IgG Reductions in the Lowest Subcutaneous Dose Tested; Announces NDA Submission for Troriluzole in SCA and Provides Other Key Program Updates  PR Newswire

Biohaven Reports Positive Phase 1 Degrader Data, Achieving Deep Targeted IgG Reductions in the Lowest Subcutaneous Dose Tested; Announces NDA Submission for Troriluzole in SCA and Provides Other Key Program Updates - PR Newswire

Click here to get full coverage on Jim Cramer on Biohaven Ltd. (BHVN): “I Think That This is a Buy” - Insider Monkey

Jim Cramer on Biohaven Ltd. (BHVN): “I Think That This is a Buy”  Insider Monkey

Jim Cramer on Biohaven Ltd. (BHVN): “I Think That This is a Buy” - Insider Monkey

Click here to get full coverage on Biohaven stock slides as FDA delays drug review (BHVN:NYSE) - Seeking Alpha

Biohaven stock slides as FDA delays drug review (BHVN:NYSE)  Seeking Alpha

Biohaven stock slides as FDA delays drug review (BHVN:NYSE) - Seeking Alpha

Click here to get full coverage on BIOHAVEN Earnings Preview: Recent $BHVN Insider Trading, Hedge Fund Activity, and More - Nasdaq

BIOHAVEN Earnings Preview: Recent $BHVN Insider Trading, Hedge Fund Activity, and More  Nasdaq

BIOHAVEN Earnings Preview: Recent $BHVN Insider Trading, Hedge Fund Activity, and More - Nasdaq

Click here to get full coverage on Biohaven Highlights Portfolio Progress, Innovation, and Anticipated Milestones at the 43rd Annual J.P. Morgan Healthcare Conference; Reports Positive Degrader Data with Rapid, Deep, and Selective Lowering of Galactose-Deficient IgA1 with Next Generatio - PR Newswire

Biohaven Highlights Portfolio Progress, Innovation, and Anticipated Milestones at the 43rd Annual J.P. Morgan Healthcare Conference; Reports Positive Degrader Data with Rapid, Deep, and Selective Lowering of Galactose-Deficient IgA1 with Next Generatio  PR Newswire

Biohaven Highlights Portfolio Progress, Innovation, and Anticipated Milestones at the 43rd Annual J.P. Morgan Healthcare Conference; Reports Positive Degrader Data with Rapid, Deep, and Selective Lowering of Galactose-Deficient IgA1 with Next Generatio - PR Newswire

Click here to get full coverage on Biohaven Stock (BHVN) Makes New 52-Week Low As Regulatory Hurdles Delay Progress - AskTraders.com

Biohaven Stock (BHVN) Makes New 52-Week Low As Regulatory Hurdles Delay Progress  AskTraders.com

Biohaven Stock (BHVN) Makes New 52-Week Low As Regulatory Hurdles Delay Progress - AskTraders.com

Click here to get full coverage on New Analyst Forecast: $BHVN Given $60.0 Price Target - Nasdaq

New Analyst Forecast: $BHVN Given $60.0 Price Target  Nasdaq

New Analyst Forecast: $BHVN Given $60.0 Price Target - Nasdaq

Click here to get full coverage on BHVN Investors Have Opportunity to Join Biohaven Ltd. Fraud Investigation with the Schall Law Firm - PR Newswire

BHVN Investors Have Opportunity to Join Biohaven Ltd. Fraud Investigation with the Schall Law Firm  PR Newswire

BHVN Investors Have Opportunity to Join Biohaven Ltd. Fraud Investigation with the Schall Law Firm - PR Newswire

Click here to get full coverage on Noteworthy Friday Option Activity: BHVN, TDUP, PAYX - Nasdaq

Noteworthy Friday Option Activity: BHVN, TDUP, PAYX  Nasdaq

Noteworthy Friday Option Activity: BHVN, TDUP, PAYX - Nasdaq

Click here to get full coverage on Biohaven Ltd. (BHVN): Among Stocks That Will Bounce Back According To Analysts - Insider Monkey

Biohaven Ltd. (BHVN): Among Stocks That Will Bounce Back According To Analysts  Insider Monkey

Biohaven Ltd. (BHVN): Among Stocks That Will Bounce Back According To Analysts - Insider Monkey

Click here to get full coverage on Biohaven Ltd. (BHVN): Among Stocks with Heavy Insider Buying in 2025 - Insider Monkey

Biohaven Ltd. (BHVN): Among Stocks with Heavy Insider Buying in 2025  Insider Monkey

Biohaven Ltd. (BHVN): Among Stocks with Heavy Insider Buying in 2025 - Insider Monkey

Click here to get full coverage on Breakthrough Parkinson's Treatment: Biohaven's Novel Brain Drug Enters Pivotal Trial for 10M Patients - Stock Titan

Breakthrough Parkinson's Treatment: Biohaven's Novel Brain Drug Enters Pivotal Trial for 10M Patients  Stock Titan

Breakthrough Parkinson's Treatment: Biohaven's Novel Brain Drug Enters Pivotal Trial for 10M Patients - Stock Titan

Click here to get full coverage on Biohaven Reports Second Quarter 2024 Financial Results and Recent Business Developments - PR Newswire

Biohaven Reports Second Quarter 2024 Financial Results and Recent Business Developments  PR Newswire

Biohaven Reports Second Quarter 2024 Financial Results and Recent Business Developments - PR Newswire

Click here to get full coverage on Biohaven's Exciting Year Of Catalysts (NYSE:BHVN) - Seeking Alpha

Biohaven's Exciting Year Of Catalysts (NYSE:BHVN)  Seeking Alpha

Biohaven's Exciting Year Of Catalysts (NYSE:BHVN) - Seeking Alpha

Click here to get full coverage on Biohaven Pharma (BHVN) Announces Investment up to $600 Million by Oberland Capital - StreetInsider

Biohaven Pharma (BHVN) Announces Investment up to $600 Million by Oberland Capital  StreetInsider

Biohaven Pharma (BHVN) Announces Investment up to $600 Million by Oberland Capital - StreetInsider

Click here to get full coverage on TD Cowen on Biohaven Pharmaceutical Holding (BHVN): 'This Pipeline Is Impressive', 'Buy BHVN' - StreetInsider

TD Cowen on Biohaven Pharmaceutical Holding (BHVN): 'This Pipeline Is Impressive', 'Buy BHVN'  StreetInsider

TD Cowen on Biohaven Pharmaceutical Holding (BHVN): 'This Pipeline Is Impressive', 'Buy BHVN' - StreetInsider

Click here to get full coverage on Biohaven (BHVN) Target Price Lowered by JP Morgan Analyst | BHVN Stock News - GuruFocus

Biohaven (BHVN) Target Price Lowered by JP Morgan Analyst | BHVN Stock News  GuruFocus

Biohaven (BHVN) Target Price Lowered by JP Morgan Analyst | BHVN Stock News - GuruFocus

Click here to get full coverage on Biohaven (BHVN) Price Target Lowered by JPMorgan to $55 | BHVN Stock News - GuruFocus

Biohaven (BHVN) Price Target Lowered by JPMorgan to $55 | BHVN Stock News  GuruFocus

Biohaven (BHVN) Price Target Lowered by JPMorgan to $55 | BHVN Stock News - GuruFocus

Click here to get full coverage on Do Analysts Think That Biohaven Pharmaceutical Holding Company Ltd. (BHVN) Is a Good GLP-1 and Weight Loss Stock to Invest In? - Yahoo Finance

Do Analysts Think That Biohaven Pharmaceutical Holding Company Ltd. (BHVN) Is a Good GLP-1 and Weight Loss Stock to Invest In?  Yahoo Finance

Do Analysts Think That Biohaven Pharmaceutical Holding Company Ltd. (BHVN) Is a Good GLP-1 and Weight Loss Stock to Invest In? - Yahoo Finance

Click here to get full coverage on Governor felicitates eminent doctors at Raj Bhavan - The Hindu

Governor felicitates eminent doctors at Raj Bhavan  The Hindu

Governor felicitates eminent doctors at Raj Bhavan - The Hindu

Click here to get full coverage on Noteworthy Thursday Option Activity: U, BHVN, RKT - Nasdaq

Noteworthy Thursday Option Activity: U, BHVN, RKT  Nasdaq

Noteworthy Thursday Option Activity: U, BHVN, RKT - Nasdaq

Click here to get full coverage on Biohaven Doses First Patient with its Novel Trop-2 Directed Antibody Drug Conjugate (ADC) BHV-1510 in Advanced or Metastatic Epithelial Tumors - PR Newswire

Biohaven Doses First Patient with its Novel Trop-2 Directed Antibody Drug Conjugate (ADC) BHV-1510 in Advanced or Metastatic Epithelial Tumors  PR Newswire

Biohaven Doses First Patient with its Novel Trop-2 Directed Antibody Drug Conjugate (ADC) BHV-1510 in Advanced or Metastatic Epithelial Tumors - PR Newswire

Click here to get full coverage on Biohaven Announces Record Date for Anticipated Spin-Off - PR Newswire

Biohaven Announces Record Date for Anticipated Spin-Off  PR Newswire

Biohaven Announces Record Date for Anticipated Spin-Off - PR Newswire

Click here to get full coverage on Down -32.76% in 4 Weeks, Here's Why Biohaven Ltd. (BHVN) Looks Ripe for a Turnaround - Yahoo Finance

Down -32.76% in 4 Weeks, Here's Why Biohaven Ltd. (BHVN) Looks Ripe for a Turnaround  Yahoo Finance

Down -32.76% in 4 Weeks, Here's Why Biohaven Ltd. (BHVN) Looks Ripe for a Turnaround - Yahoo Finance

Click here to get full coverage on Biohaven Nabbed A Nearly $12 Billion Buyout — What's Next? - Investor's Business Daily

Biohaven Nabbed A Nearly $12 Billion Buyout — What's Next?  Investor's Business Daily

Biohaven Nabbed A Nearly $12 Billion Buyout — What's Next? - Investor's Business Daily

Click here to get full coverage on Goa: Polar Bhavan and Sagar Bhavan centres to play strategic role in Ocean geopolitics - - News On AIR

Goa: Polar Bhavan and Sagar Bhavan centres to play strategic role in Ocean geopolitics -  News On AIR

Goa: Polar Bhavan and Sagar Bhavan centres to play strategic role in Ocean geopolitics - - News On AIR

Click here to get full coverage on Biohaven Acquires Kv7 Ion Channel Platform for the Treatment of Epilepsy and Other Neurologic Disorders From Channel Biosciences, a Subsidiary of Knopp Biosciences - PR Newswire

Biohaven Acquires Kv7 Ion Channel Platform for the Treatment of Epilepsy and Other Neurologic Disorders From Channel Biosciences, a Subsidiary of Knopp Biosciences  PR Newswire

Biohaven Acquires Kv7 Ion Channel Platform for the Treatment of Epilepsy and Other Neurologic Disorders From Channel Biosciences, a Subsidiary of Knopp Biosciences - PR Newswire

Biohaven Pharmaceutical Holding Co Ltd (BHVN)

Price Chart

Key Statistics

Technicals

About BHVN

Latest News

What drives BHVN stock price - Remarkable growth - Jammu Links News

Law Offices of Frank R. Cruz Encourages Biohaven Ltd. (BHVN) Investors To Inquire About Securities Fraud Class Action - Business Wire

Biohaven Ltd. (BHVN) Collaborates with Bexorg, Inc to Target Central Nervous System Disorders - yahoo.co

Advanced Charts

Top Gainers

Top Losers